CVS, Omnicare ink $440M deal with DoJ to resolve improper billing case
Seeking Alpha ·
CVS Health ( CVS ) and its subsidiary Omnicare have agreed to pay $440M to the Department of Justice to resolve a lawsuit that accused the senior care pharmacy of improperly charging the federal government for false prescription drug claims.
DYAX Investor Sentiment
Bullish (Long) 62% · Bearish (Short) 38%
321 participants
Related News
- Corning shares jump 6%, snapping a six-day losing streak
- Kaiser Aluminum cut to Sell equivalent at Wells Fargo as valuation looks stretched
- Six Months In, AZA Law Firm’s Dallas Office Tracks Toward Its Year-One Plan
- Meet the Low-Cost Vanguard ETF Beating the S&P 500 in 2026 That Many Investors Are Overlooking
- CVX Stock Has A New Bull Case — Why Bank Of America Favors Chevron Over Exxon As Hormuz Risks Push Oil Prices Higher
- Musk calls rival Anthropic the current frontrunner in AI